CEUS for Blunt Abdominal Trauma in Children

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age0-17
SponsorChildren's Hospital of Philadelphia

About this trial

Children with blunt abdominal trauma often get a CT as the first line imaging to evaluate for intra-abdominal organ injury. CT scans have some downsides with regard to radiation exposure, costs, and need for transport. Contrast enhanced ultrasonography has recently shown some promise as a way to detect intra-abdominal organ injury and may be able to replace the need for conventional CT scanning, without the need for ionizing radiation and the ability to be performed at the bedside.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Hemodynamically stable (defined as not needing massive transfusion protocol and not undergoing an emergent surgical procedure within the next hour)

History of or suspicion for blunt abdominal trauma

Abdominal CT ordered or obtained

Disqualifiers

History of allergic reaction to Lumason, sulfur hexaflouride, sulfur hexafluoride lipid microsphere components, or other ingredients in Lumason (polyethylene glycol, distearoylphosphatidylcholine (DSPC), dipalmitoylphosphatidylglycerol sodium (DPPG-Na), palmitic acid)

Co-existing penetrating abdominal trauma

Known congenital or acquired heart disease

Trial design

Design model

Single group

Treatments tested in this trial

  • Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]

    Drug

    injection of Lumason (ultrasound contrast agent)

  • contrast-enhanced ultrasound

    Device

    ultrasound of the abdomen after injection of ultrasound contrast agent (Lumason)

Treatment groups

146 Participants
are divided into 1 treatment group
Group A: Contrast-enhanced ultrasound armExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Sensitivity of CEUS

calculation of sensitivity of CEUS for organ injury, as compared to gold standard CT

Time frame
through study completion, which is expected to take around 3 years
2

Specificity of CEUS

calculation of specificity of CEUS for organ injury, as compared to gold standard CT exam

Time frame
through study completion, which is expected to take around 3 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.